Elsevier

Virology

Volumes 479–480, May 2015, Pages 247-258
Virology

Review
Development of animal models against emerging coronaviruses: From SARS to MERS coronavirus

https://doi.org/10.1016/j.virol.2015.02.030Get rights and content
Under an Elsevier user license
open archive

Highlights

  • We discuss the development of animal models for SARS and MERS-CoV.

  • Strategies to develop models for the FDA “Animal Rule” are illustrated.

  • Host range is discussed in the context of viral receptor heterogeneity.

Abstract

Two novel coronaviruses have emerged to cause severe disease in humans. While bats may be the primary reservoir for both viruses, SARS coronavirus (SARS-CoV) likely crossed into humans from civets in China, and MERS coronavirus (MERS-CoV) has been transmitted from camels in the Middle East. Unlike SARS-CoV that resolved within a year, continued introductions of MERS-CoV present an on-going public health threat. Animal models are needed to evaluate countermeasures against emerging viruses. With SARS-CoV, several animal species were permissive to infection. In contrast, most laboratory animals are refractory or only semi-permissive to infection with MERS-CoV. This host-range restriction is largely determined by sequence heterogeneity in the MERS-CoV receptor. We describe animal models developed to study coronaviruses, with a focus on host-range restriction at the level of the viral receptor and discuss approaches to consider in developing a model to evaluate countermeasures against MERS-CoV.

Keywords

Coronaviruses
SARS-CoV
MERS-CoV
Animal models
Receptor

Cited by (0)